Gabapentin Withdrawal: Symptoms, Timeline & Detox

Gabapentin withdrawal can happen when someone who has used gabapentin regularly stops suddenly or reduces their dose too quickly. Over time, the nervous system can adjust to the drug’s effects. When the dose drops too quickly, the body may react with physical, emotional or neurological symptoms (Athavale et al., 2023).

The experience can vary based on dose, length of use, reason for taking it, kidney function, other substance use and whether the medication is tapered under medical supervision.

Gabapentin is commonly prescribed to help prevent seizures and treat nerve pain. Although it is not federally controlled under the Controlled Substances Act, some states have added scheduling or prescription monitoring requirements because of misuse concerns (DEA, 2026; Combs et al., 2025). Because abrupt discontinuation can cause withdrawal symptoms or increase seizure risk, dose changes should be discussed with a healthcare provider (Pfizer, 2017).

What Happens When You Stop Gabapentin? Physical Symptoms, Mood Changes and Rebound Effects

Gabapentin withdrawal is more likely after long-term use, higher doses, misuse or use with alcohol, opioids, benzodiazepines or other central nervous system depressants. Reviews of gabapentinoid misuse and dependence describe withdrawal symptoms as a potential concern, especially among people using higher doses or combining gabapentin with other substances (McNeilage et al., 2024).

It can affect the body, mood, thinking, sleep and the condition the drug was originally prescribed to treat. Some individuals experience mild discomfort, while others may have more serious symptoms.

Symptom Type	Possible Effects
Physical symptoms	Sweating, nausea, headache, dizziness, fatigue, body aches, stomach pain, tremors, muscle twitching or heart palpitations
Psychological symptoms	Anxiety, agitation, irritability, mood swings, depression, restlessness, confusion or trouble concentrating
Sleep-related effects	Insomnia, restless sleep, frequent waking or vivid dreams
Rebound effects	Return or worsening of nerve pain, seizures, anxiety, restless legs or other issues gabapentin was helping manage
Serious effects	Seizures, severe confusion, hallucinations, chest pain, fainting, trouble breathing or thoughts of self-harm

Gabapentinoid withdrawal has been associated with anxiety, insomnia, nausea, sweating, pain, tremor and mood changes (Athavale et al., 2023). Severe or worsening symptoms, especially seizures, suicidal thoughts, respiratory symptoms, severe confusion or extreme agitation, should be treated as urgent health concerns (DailyMed, 2025; Pfizer, 2017).

Rebound effects happen when the original condition gabapentin was helping manage comes back or worsens after the dose is reduced. For example, someone using it for nerve pain may notice pain returning during a taper. This does not always mean withdrawal is dangerous, but it may mean the taper plan or treatment plan needs to be adjusted.

Timeline: How Long Symptoms May Last

Gabapentin withdrawal does not follow the exact same timeline for everyone. Timing may depend on dose, length of use, taper speed, kidney function, age, seizure history and whether other substances are involved.

Timeframe	What May Happen
12–48 hours after the last dose	Early withdrawal symptoms may begin, including anxiety, sweating, nausea, restlessness, insomnia, headache or body discomfort.
Days 2–7	Effects may become more noticeable or peak. Some people experience agitation, confusion, stomach pain, tremors, palpitations, sleep disruption or rebound pain.
Days 7–14	Many people begin to improve, but sleep problems, anxiety, mood changes or pain may continue.
Several weeks or longer	Lingering effects are possible, especially after long-term use, high-dose use, rapid tapering, older age or use with other substances.

A therapeutic review of gabapentinoids reports that withdrawal symptoms can occur within 12 hours to seven days after stopping the medication (Athavale et al., 2023). Case reports also show that some people may need much slower, individualized tapers when gabapentin dependence is severe or symptoms persist (Deng et al., 2021).

Seek help right away if gabapentin withdrawal includes seizures, severe confusion, hallucinations, chest pain, fainting, trouble breathing, severe agitation or thoughts of self-harm.

Can You Stop This Medication Cold Turkey?

You should not stop this medication cold turkey without guidance from a healthcare provider. Stopping suddenly can cause withdrawal symptoms and may increase seizure risk, especially in people who use it for seizure control or who have a seizure history.

A provider may recommend a gradual taper instead. Tapering means slowly lowering the dose over time so the body can adjust more safely. The Neurontin prescribing information recommends reducing or discontinuing gabapentin gradually over at least one week, with a longer period when clinically needed (Pfizer, 2017).

Can Withdrawal Syndrome Happen Even With a Taper?

A taper can reduce the risk and severity of withdrawal syndrome, but it does not guarantee that symptoms will not happen. Some people develop symptoms even after tapering, especially after long-term use, higher doses, older age or complex health histories.

This does not mean tapering is ineffective. It means the taper should be individualized. Some people may need a slower dose reduction over several weeks or months rather than a short taper, especially if symptoms appear each time the dose is lowered. A case report on severe gabapentin dependence described the need for a patient-centered, slow taper when withdrawal symptoms were difficult to manage (Deng et al., 2021).

A provider may slow the taper if symptoms become difficult to manage. In some cases, the provider may temporarily adjust the dose before restarting the taper more gradually.

What Affects Severe Withdrawal Risk?

Gabapentin withdrawal is not the same for everyone. Several factors can affect how intense the experience is and how long it lasts.

Factor	Why It Matters
Dose	Higher doses may increase the risk of more intense effects.
Length of use	Long-term use can make it harder for the body to adjust after stopping.
Taper speed	Reducing the dose too quickly can increase discomfort and health risks.
Kidney function	Gabapentin is cleared through the kidneys, so kidney problems can affect how long it stays in the body.
Seizure history	People using gabapentin for seizures may be at higher risk if they stop abruptly.
Other substances	Alcohol, opioids, benzodiazepines and sedatives can increase safety risks.
Misuse or dependence	Misuse may increase the risk of cravings, withdrawal and relapse.
Age and health history	Older adults or people with multiple health conditions may need closer monitoring.

Gabapentin is primarily eliminated through the kidneys, so impaired kidney function can affect drug clearance and dosing needs (Yasaei et al., 2024). People with these risk factors should speak with a healthcare provider before reducing or stopping it.

When to Get Medical Help

Support from a healthcare provider is important before stopping gabapentin, especially for people who take high doses, have used it long term, have kidney problems, have a seizure history, are older adults or use alcohol, opioids, benzodiazepines or sedatives (FDA, 2019; Yasaei et al., 2024).

Seek urgent help if symptoms include:

• Seizures
  
  
• Severe confusion
  
  
• Severe agitation
  
  
• Hallucinations
  
  
• Chest pain
  
  
• Fainting
  
  
• Trouble breathing
  
  
• Severe heart palpitations
  
  
• Symptoms that are getting worse
  
  
• Thoughts of self-harm
  
  

Gabapentin withdrawal can often be managed safely with the right guidance, but severe or worsening symptoms should be evaluated quickly.

How to Stop Safely: Tapering Gabapentin

The safest way to stop is usually through a provider-guided taper. There is no single taper schedule that works for everyone. Some people may reduce their dose over several days, while others may need a slower taper over weeks or longer.

The current package insert recommends reducing gabapentin gradually over at least one week when stopping the medication. However, tapering gabapentin may take longer depending on the person’s dose, symptoms and health history (Pfizer, 2017).

A provider may consider:

• Current dose
  
  
• Length of use
  
  
• Seizure history
  
  
• Kidney function
  
  
• Withdrawal symptoms
  
  
• Other medications
  
  
• Alcohol, opioid, benzodiazepine or sedative use
  
  
• Whether gabapentin was misused
  
  
• The condition the drug was prescribed to treat
  
  

Before reducing or stopping gabapentin, helpful questions to ask include:

• What taper schedule do you recommend for my dose?
  
  
• How long should my taper take?
  
  
• What effects should I expect?
  
  
• Which effects require urgent help?
  
  
• What should I do if symptoms become difficult to manage?
  
  
• Could my original condition, such as nerve pain, anxiety or seizures, return?
  
  
• Do I need a slower taper because of my age, kidney function or health history?
  
  
• Should I avoid alcohol, opioids or sedatives while tapering?
  
  
• How often should I check in during the taper?
  
  

Do not change your dose suddenly unless a healthcare provider tells you to do so.

How to Manage Mild Symptoms

Mild withdrawal symptoms may be manageable with provider guidance and supportive care. A provider may recommend strategies such as:

• Staying hydrated
  
  
• Eating regular meals
  
  
• Keeping a consistent sleep schedule
  
  
• Avoiding alcohol and non-prescribed sedatives
  
  
• Tracking symptoms each day
  
  
• Using relaxation strategies for anxiety or restlessness
  
  
• Following up regularly with the prescribing provider
  
  
• Discussing short-term symptom relief when appropriate
  
  

A symptom tracker can be useful during tapering. Recording the dose, sleep quality, mood, discomfort and what helped can give the provider better information if the taper needs to be adjusted.

Detox and Withdrawal Treatment

Gabapentin detox is the process of managing withdrawal while the body adjusts to lower levels of the drug. Some people may be able to taper at home with provider guidance, but others may need a supervised treatment setting.

Professional medical detox may involve:

• Health evaluation
  
  
• Medication review
  
  
• Gradual tapering when appropriate
  
  
• Monitoring for seizures, confusion or severe agitation
  
  
• Support for anxiety, insomnia, pain or restlessness
  
  
• Hydration and nutrition support
  
  
• Help managing co-occurring alcohol, opioid, benzodiazepine or sedative use
  
  
• Planning for ongoing treatment if misuse or addiction is present
  
  

Detox focuses on helping someone get through the immediate withdrawal period as safely and comfortably as possible. If gabapentin was misused, or if other substances are involved, detox may be followed by addiction treatment, mental health care, therapy or pain management support to address the underlying reasons for misuse and reduce relapse risk (NIDA, 2024).

Dependence, Misuse and Addiction

Dependence, misuse and addiction are related but not the same.

Physical dependence can happen when the body adjusts to regular use and reacts when the dose is reduced or stopped. This can happen even when someone uses the drug as prescribed.

Misuse means using gabapentin in a way other than prescribed. This may include higher doses, using someone else’s prescription, using it to feel intoxicated or combining it with alcohol, opioids or other drugs. A 2024 qualitative systematic review found that motives for gabapentinoid misuse included getting high, self-medicating distress or pain, managing withdrawal symptoms or substituting for another drug (McNeilage et al., 2024).

Addiction involves compulsive use, cravings, loss of control or continued use despite negative consequences. A person may be physically dependent without having an addiction, but misuse can increase the risk of stronger withdrawal symptoms, cravings and difficulty stopping.

Signs that gabapentin use may have become problematic include:

• Taking more than prescribed
  
  
• Running out early
  
  
• Using gabapentin without a prescription
  
  
• Mixing it with alcohol, opioids, benzodiazepines or sedatives
  
  
• Feeling unable to cut back
  
  
• Cravings
  
  
• Continuing use despite negative effects
  
  
• Withdrawal symptoms when reducing or stopping
  
  

Professional help may be needed if use feels difficult to control or if gabapentin withdrawal makes it hard to stop.

Alcohol and Opioid Interactions

Gabapentin can slow activity in the central nervous system. Alcohol, opioids, benzodiazepines and sedatives can have similar effects. When used together, their effects can stack, increasing the risk of severe drowsiness, impaired coordination, slowed thinking, breathing problems, overdose and other serious complications.

The FDA has warned that serious breathing problems may occur when gabapentin or pregabalin are used by people with respiratory risk factors, including use with opioids or other central nervous system depressants (FDA, 2019). A review of respiratory concerns also highlights increased risk when gabapentinoids are combined with other depressant substances (Shrestha & Palaian, 2021).

People who use gabapentin with alcohol, opioids or sedatives should speak with a healthcare provider before making changes. Detox or treatment may be safer in a supervised setting when multiple substances are involved.

How Long Does Gabapentin Stay in Your System?

Gabapentin has a half-life of about five to seven hours, which means it takes that amount of time for the body to eliminate about half of a dose. It is often taken multiple times per day because of this relatively short half-life.

Gabapentin is not heavily metabolized by the liver. Instead, it is eliminated mostly unchanged through the kidneys. Poor kidney function can cause it to stay in the body longer (Yasaei et al., 2024).

Routine drug tests do not usually test for gabapentin, but a specific test can detect it. The drug may be detectable in blood for several hours and in urine for one to two days, though detection can vary based on health and testing factors.

Reasons Someone May Stop Taking It

People may stop using gabapentin for different reasons. No matter the reason, stopping should be discussed with a healthcare provider first.

Common reasons include:

• It is not helping: The drug may take time to work, depending on why it was prescribed. If it is not effective, a provider may recommend a different approach.
  
  
• Side effects are bothersome: Drowsiness, dizziness and coordination issues are known side effects and can make the drug difficult for some people to tolerate (Pfizer, 2017).
  
  
• It was only needed short term: Some people use it for a limited period, such as after surgery.
  
  
• Symptoms have improved: Feeling better may mean the medication is working, not necessarily that it is safe to stop.
  
  
• There are safety concerns: Misuse, combining it with other substances or using more than prescribed may require professional help.
  
  

Long-Term Care After Symptoms Improve

Stopping gabapentin may be only one part of the process. Many people still need care for the condition it was originally treating, such as nerve pain, seizures, anxiety, restless legs or mood concerns.

A long-term care plan may include:

• Alternative medications
  
  
• Pain management support
  
  
• Neurology follow-up for seizure disorders
  
  
• Therapy or mental health treatment
  
  
• Physical therapy
  
  
• Sleep support
  
  
• Substance use treatment if gabapentin was misused
  
  
• Relapse prevention planning if cravings or compulsive use are present
  
  

Gabapentin detox can help with the immediate withdrawal period, but ongoing treatment may be needed to address the underlying condition, substance use pattern or recovery needs.

Drug Detox in West Palm Beach

If you or a loved one are struggling with gabapentin misuse or addiction, The Recovery Village at Baptist Health can help. Our team of licensed, experienced professionals create personalized, evidence-based treatment plans designed around your needs and situation. Our full continuum of care includes medical detox, inpatient, partial hospitalization, outpatient and aftercare programs. Contact us today to begin your journey to a healthier life in recovery.

References

Athavale, A., Banerjee, S., & Soni, P. (2023). Gabapentinoids: A therapeutic review. Australian Prescriber, 46(6), 174–180.
https://pmc.ncbi.nlm.nih.gov/articles/PMC10751078/

Combs, K. G., Vickers-Smith, R., Freeman, P. R., & Smith, R. V. (2025). A comprehensive analysis of jurisdiction-specific laws related to scheduling or required prescription drug monitoring of gabapentin in the United States, 2016–2024.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12676011/

DailyMed. (2025). Gabapentin tablets prescribing information. National Library of Medicine.
https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=3cfd04ab-e421-441f-a10e-e4dd1412974d&type=display

Deng, H., Beamer, M. P., & Grierson, R. (2021). Gabapentin dependence and withdrawal requiring an 18-month taper in a patient with chronic pain. Journal of Addiction Medicine, 15(5), 440–442.
https://pubmed.ncbi.nlm.nih.gov/33783336/

Drug Enforcement Administration. (2026). Gabapentin: Drug fact sheet.
https://www.deadiversion.usdoj.gov/drug_chem_info/gabapentin.pdf

Evoy, K. E., Peckham, A. M., Covvey, J. R., & Tidgewell, K. J. (2021). Gabapentinoid pharmacology in the context of emerging misuse liability. The Journal of Clinical Pharmacology, 61(S2), S89–S99.
https://pubmed.ncbi.nlm.nih.gov/34396549/

Food and Drug Administration. (2019). FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin and pregabalin.
https://www.fda.gov/safety/medical-product-safety-information/neurontin-gralise-horizant-gabapentin-and-lyrica-lyrica-cr-pregabalin-drug-safety-communication

McNeilage, A. G., Sim, A., Nielsen, S., Murnion, B., & Ashton-James, C. E. (2024). Experiences of misuse and symptoms of dependence among people who use gabapentinoids: A qualitative systematic review. International Journal of Drug Policy, 130, 104605.
https://pubmed.ncbi.nlm.nih.gov/39388918/

National Institute on Drug Abuse. (2024). Treatment and recovery.
https://nida.nih.gov/publications/drugs-brains-behavior-science-addiction/treatment-recovery

Pfizer. (2017). Neurontin (gabapentin) prescribing information. U.S. Food and Drug Administration.
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020235s064_020882s047_021129s046lbl.pdf

Shrestha, S., & Palaian, S. (2021). Respiratory concerns of gabapentin and pregabalin. F1000Research, 10, 31.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7919607/

Yasaei, R., Katta, S., & Saadabadi, A. (2024). Gabapentin. StatPearls. National Library of Medicine.
https://www.ncbi.nlm.nih.gov/books/NBK493228/